These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29120522)

  • 1. Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload.
    Fernández-Ruiz M; Parra P; Ruiz-Merlo T; López-Medrano F; San Juan R; Polanco N; González E; Andrés A; Aguado JM
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29120522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients.
    Fernández-Ruiz M; López-Medrano F; Andrés A; Morales JM; Lumbreras C; San-Juan R; Polanco N; González E; Aguado JM
    Transpl Infect Dis; 2013 Dec; 15(6):600-11. PubMed ID: 24011120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.
    Boga S; Alkim H; Alkim C; Koksal AR; Bayram M; Yilmaz Ozguven MB; Tekin Neijmann S
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):293-300. PubMed ID: 26405701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation.
    Fernández-Ruiz M; Parra P; López-Medrano F; Ruiz-Merlo T; González E; Polanco N; Origüen J; San Juan R; Andrés A; Aguado JM
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28122147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents.
    Inomata S; Anan A; Yamauchi E; Yamauchi R; Kunimoto H; Takata K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Irie M; Shakado S; Sohda T; Sakisaka S
    Intern Med; 2019 Oct; 58(20):2915-2922. PubMed ID: 31243222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of serum haemojuvelin and hepcidin levels with iron level and erythropoietin requirement in prevalent hepatitis C virus positive haemodialysis patients.
    El Said HW; Abou Seif KH; Ahmed YS; Abou Elleil HA; El Said TW; Behairy MA; Mohamed MM; Ahmed FA
    Nephrology (Carlton); 2018 Apr; 23(4):323-330. PubMed ID: 28130911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
    Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Overload in Renal Transplant Patients: The Role of Hepcidin and Erythropoietin.
    Bilar JM; Fucuta PDS; Feldner AC; Caravalho Filho R; Silva I; Pestana JM; Ferraz ML
    Transplant Proc; 2020; 52(1):169-174. PubMed ID: 31955851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hepcidin level correlates with hyperlipidemia status in patients following allograft renal transplantation.
    Xue D; He X; Zhou C
    Transplant Proc; 2014; 46(1):156-9. PubMed ID: 24507043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
    Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
    Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
    Gu S; Song X; Zhao Y; Guo J; Fei C; Xu F; Wu L; Zhang X; Zhao J; Chang C; Li X
    Hematology; 2013 Sep; 18(5):286-94. PubMed ID: 23540794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome.
    Zipperer E; Post JG; Herkert M; Kündgen A; Fox F; Haas R; Gattermann N; Germing U
    Ann Hematol; 2013 Dec; 92(12):1617-23. PubMed ID: 23842708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation.
    Kanda J; Mizumoto C; Kawabata H; Ichinohe T; Tsuchida H; Tomosugi N; Matsuo K; Yamashita K; Kondo T; Ishikawa T; Uchiyama T
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):956-62. PubMed ID: 19589485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of hepcidin-25 with survival after kidney transplantation.
    Eisenga MF; Dullaart RP; Berger SP; Sloan JH; de Vries AP; Bakker SJ; Gaillard CA
    Eur J Clin Invest; 2016 Dec; 46(12):994-1001. PubMed ID: 27696386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum iron in preeclamptic women is likely due to low hepcidin levels.
    Brunacci F; Rocha VS; De Carli E; Espósito BP; Ruano R; Colli C
    Nutr Res; 2018 May; 53():32-39. PubMed ID: 29685625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In alcoholic cirrhosis, low-serum hepcidin levels associate with poor long-term survival.
    Nahon P; Nuraldeen R; Rufat P; Sutton A; Trautwein C; Strnad P
    Liver Int; 2016 Feb; 36(2):185-8. PubMed ID: 26561367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
    Mangaonkar AA; Thawer F; Son J; Ajebo G; Xu H; Barrett NJ; Wells LG; Bowman L; Clair B; Patel N; Bora P; Jung G; Nemeth E; Kutlar A
    Br J Haematol; 2020 Jun; 189(6):1204-1209. PubMed ID: 32030737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hepcidin antimicrobial peptide on iron overload in tuberculosis patients.
    Javaheri-Kermani M; Farazmandfar T; Ajami A; Yazdani Y
    Scand J Infect Dis; 2014 Oct; 46(10):693-6. PubMed ID: 25134646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.